Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pamela Maher has a total of 221 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Methylglyoxal Impairs Mitochondrial Bioenergetics and Microglial Functions

    by Taketo Taguchi, Pamela Maher

    Aging is accompanied by a progressive disruption of brain homeostasis, yet the molecular mechanisms underlying this age-associated deterioration remain poorly understood. Microglia play a critical role in maintaining brain homeostasis by clearing cellular debris and neurotoxic protein aggregates. Here, we investigated the effects of methylglyoxal (MG), a highly reactive endogenous metabolite that accumulates with aging, on microglial functions using the murine microglial cell line BV2. We assessed the effects of MG exposure on multiple aspects of microglial biology in both control and bacterial lipopolysaccharide (LPS)-treated cells, including phagocytic activity, cellular proliferation, cytokine secretion, mitochondrial bioenergetics, mitochondrial membrane potential, and intracellular and mitochondrial reactive oxygen species. We found that MG significantly impaired mitochondrial bioenergetics, leading to reduced cellular energy production, and markedly suppressed multiple essential microglial functions, including phagocytosis. Given the high reactivity of MG with arginine, we also investigated whether arginine depletion contributes to these functional impairments. Arginine depletion recapitulated the impairment of mitochondrial bioenergetics and microglial function induced by MG, demonstrating that arginine availability is a critical determinant of microglial metabolic fitness and immune function. These findings suggest that the age-associated accumulation of MG impairs mitochondrial bioenergetics and microglial functions, thereby potentially accelerating neurodegenerative processes.

  • Open Access

    Review of: "The Future of Longevity Medicine: Repairing the Parts or Preserving the Whole?Holmes’ Carriage as a Metaphor for Two Fundamentally Different Models of Aging"

    by Pamela Maher

    The authors of this manuscript present a very interesting concept to consider in the context of aging, which is the loss of systemic coherence. For the most part, their ideas are clearly presented. However, the rationale for the choice of the basic m...

  • Open Access

    Acid ceramidase modulates the lipid profile and exacerbates sensitivity to ferroptosis in WI-38 replicative senescent cells

    by David Soriano-Castell, Marie Goujon, Nawab John Dar, Antonio Currais, Pamela Maher

    Cellular senescence, a complex biological process characterized by irreversible cell cycle arrest and the senescence-associated secretory phenotype, has emerged as a critical target for therapeutic development for age-related diseases. Ferroptosis, an iron-dependent regulated cell death pathway driven by the accumulation of lipid peroxidation in cell membranes, has been implicated in age-related disorders. This study investigated the relationship between cellular senescence and ferroptosis. Using human fetal lung WI-38 fibroblasts induced to senesce via replicative exhaustion, we report a novel role for acid ceramidase (ACase), which breaks down ceramides into sphingosine and free fatty acids, in regulating the sensitivity of senescent cells to RSL3-induced lipid peroxidation and ferroptosis through the modulation of polyunsaturated fatty acid composition of membrane phospholipids. Furthermore, we demonstrate a cell non-autonomous paracrine sensitization of non-senescent cells to ferroptosis by senescent cells. Together, these findings unveil ACase as a novel regulator of the ferroptosis pathway and open promising therapeutic avenues for targeting senescence-linked disorders and advancing healthy aging strategies.

  • Open Access

    Sustained dysregulation of iron and glutathione homeostasis induces chronoferroptosis, a persistent ferroptotic adaptation in neuronal cells

    by Nawab John Dar, David Soriano-Castell, Pamela Maher

    Although iron accumulates in brain regions impacted by neurodegenerative diseases such as Alzheimer’s and Parkinson’s, how chronic elevated iron levels contribute to neuronal dysfunction remains unclear. Here, we show that sustained iron overload, but not acute exposure, leads to a state of ferroptotic stress where nerve cells remain viable but become hypersensitive to oxidative injury. Retinoic acid-differentiated SH-SY5Y neuronal cells were exposed to acute (6–8 h) or chronic (9 days) iron loading to model transient versus prolonged age-related iron stress. While acute iron exposure produced minimal biochemical changes and did not sensitize cells to oxidative or ferroptotic challenges, chronic iron exposure induced ferritin upregulation, mitochondrial superoxide accumulation, suppression of GPX4 expression, elevated lipid peroxidation and loss of cellular glutathione (GSH). In addition, chronic but not acute GSH depletion by buthionine sulfoximine (BSO) recapitulated the iron-induced phenotype. Cells under chronic ferroptotic stress exhibited increased sensitivity not only to the ferroptosis inducer RSL-3 but also to hydrogen peroxide. Ferrostatin-1 significantly mitigated these effects suggesting that lipid peroxidation drives this state. Together, these findings demonstrate that, in contrast with acute exposure, chronic disruption of iron homeostasis with consequent GSH depletion remodels cellular redox homeostasis over time, inducing a state we term chronoferroptosis: a persistent ferroptotic adaptation characterized by coordinated alterations in iron-handling and antioxidant defense proteins that may represent early vulnerability to neurodegenerative pathology. Thus, these studies highlight the importance of sustained stress paradigms for modeling the progressive nature of neurodegenerative diseases.


  • Open Access

    Neuroprotective and anti-inflammatory activity of Wyethia species: therapeutic potential for neurodegenerative diseases

    by Idowu Jonas Sagbo, David Soriano-Castell, Jon Rebman, Pamela Maher

    Neurodegenerative diseases such as Alzheimer’s disease involve regulated forms of cell death, including oxytosis/ferroptosis, which are driven by oxidative stress and neuroinflammation. Targeting these regulated cell death pathways offers novel therapeutic opportunities. Wyethia is a small genus of flowering plants native to North America, traditionally used by Indigenous populations for medicinal purposes. Its ethnobotanical relevance and phytochemical diversity prompted investigation into its neuroprotective potential. This study examined eight Wyethia species for anti-inflammatory and neuroprotective activities. We evaluated protection against oxytosis/ferroptosis (induced by glutamate, erastin, and RSL3) in HT22 neuronal cells, energy loss using an ischemia assay in HT22 cells, and LPS-induced inflammation in BV2 microglial cells. W. ovata , W. helenioides , W. amplexicaulis and W. glabra exhibited strong neuroprotection (EC 50 < 25 μg/mL), with W. ovata also demonstrating potent anti-inflammatory activity (EC 50 = 15.2 μg/mL). Antioxidant assays (DPPH, lipid peroxidation) and measurement of total phenolic content (TPC) analysis revealed a correlation between high phenolic content and antioxidant activity, with W. ovata and W. amplexicaulis showing the highest TPC values (120–140 mg GAE/g). However, W. invenusta displayed strong neuroprotective effects despite low TPC, suggesting that other bioactive compounds such as terpenoids, or alkaloids may contribute to its activity. This highlights the complexity of phytochemical profiles and the potential presence of potent constituents beyond phenolics. These findings position Wyethia as a promising source of dual-action neuroprotective agents that target both oxytosis/ferroptosis and inflammation, warranting further phytochemical investigation.


  • Open Access

    Acid ceramidase modulates the lipid profile and exacerbates sensitivity to ferroptosis in senescent cells

    by David Soriano-Castell, Marie Goujon, Nawab Dar, Antonio Currais, Pamela Maher

    Cellular senescence, a complex biological process characterized by irreversible cell cycle arrest and the senescence-associated secretory phenotype, has emerged as a critical target for therapeutic development for age-related diseases. Ferroptosis, an iron-dependent regulated cell death pathway driven by the accumulation of lipid peroxidation in cell membranes, has been implicated in neurodegenerative diseases and other age-related disorders. This study investigated the relationship between cellular senescence and ferroptosis. Using human fetal lung Wi-38 fibroblasts induced to senesce via replicative exhaustion, we report a novel role for acid ceramidase (ACase), which breaks down ceramides into sphingosine and free fatty acids, in regulating the sensitivity of senescent cells to lipid peroxidation and ferroptosis through the modulation of polyunsaturated fatty acid composition of membrane phospholipids. Furthermore, we demonstrate a cell non-autonomous paracrine sensitization of non-senescent cells to ferroptosis by senescent cells. Together, these findings unveil ACase as a novel regulator of the ferroptosis pathway and open promising therapeutic avenues for targeting senescence-linked disorders and advancing healthy aging strategies.

  • Open Access

    Gender-Dependent Cognitive and Metabolic Benefits Due to Glyoxalase 1 (Glo1) Overexpression in Age-Accelerated SAMP8 Mice

    by Alcir Luiz Dafre, Taketo Taguchi, Yelena Dayn, Antonio Currais, Pamela Maher

    As the size of the elderly population increases, the need for an improved understanding of what leads to the age-related decline in physiological function continues to grow. SAMP8 mice were selected for their accelerated aging phenotype. The low levels of glyoxalase 1 (Glo1), the main enzyme that removes the reactive dicarbonyl methylglyoxal (MGO), in the cerebral cortex of SAMP8 mice prompted us to produce the first transgenic mice overexpressing Glo1 against the SAMP8 background, aimed at rescuing the accelerated aging phenotype. Selected health and biochemical endpoints were assessed in ten-month-old SAMP8 mice overexpressing Glo1. Glo1 overexpression increased median survival in males (21%) and females (4.6%), which was associated with better memory performance. Glo1 overexpression also increased synaptic markers (synaptophysin and SNAP25) as well as markers of mitochondrial function (NDUFB8, SDHB) and negative modulators of oxytosis/ferroptosis (NQO1, FTH1, and GPx4) in the cerebral cortex. For all parameters analyzed, the effect of Glo1 overexpression was more pronounced in males. Overall, the data support the beneficial effects of overexpressing Glo1 in multiple tissues, especially in SAMP8 males, suggesting a possible gender effect of MGO in aging. Both modulation of oxytosis/ferroptosis and mitochondrial metabolism warrant further investigation as potential mechanisms underlying the improved health span of Glo1 mice.


  • Open Access

    Cannabinol (CBN) alleviates age-related cognitive decline by improving synaptic and mitochondrial health

    by Nawab John Dar, Antonio Currais, Taketo Taguchi, Nick Andrews, Pamela Maher


  • Open Access

    Affinity‐Based Protein Profiling Reveals IDH2 as a Mitochondrial Target of Cannabinol in Receptor‐Independent Neuroprotection

    by Eva Schaller, Stephanie Lamer, Andreas Schlosser, Christian Stigloher, Pamela Maher, Michael Decker

    Phytocannabinoids are attracting growing attention because of their potential for treatment of neurodegenerative diseases. Among them, the “minor” cannabinoid, cannabinol (CBN), has emerged as a promising neuroprotective agent, acting independently of classical cannabinoid receptors through as‐yet unidentified mitochondrial targets. To uncover the molecular basis of its neuroprotective effects, we designed and synthesized a chemical probe based on CBN, incorporating a minimalist diazirine linker. Functional assays confirmed that the probe retains CBN's mitochondrial activity and exhibits strong mitochondrial enrichment, as demonstrated by fluorescence microscopy and click‐correlative light and electron microscopy (click‐CLEM). By affinity‐based protein profiling (AfBPP), we identified isocitrate dehydrogenase 2 (IDH2) as a key mitochondrial target of CBN. This finding was further substantiated by siRNA knockdown studies, which revealed that the absence of IDH2 partially phenocopies CBN's effects, validating its role as a critical mediator of CBN's neuroprotective activity.